Cysto-conray Ii Injection
Product Images NDC 0019-0862

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cysto-conray Ii (NDC 0019-0862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Liebel-flarsheim Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cysto Conray Ii 1)

Chemical structure of iothalamate meglumine, showing molecular formulas and arrangement of atoms with molecular weight 809.12.*

FDA Label Image

Principal Display Panel (Cysto Conray Ii 2)

Cysto-Conray II 172 mg/mL Iothalamate meglumine injection ureteral sterile solution in a 250 mL single-dose container. Label states not for intravascular or intrathecal use. Contains 17.2% Iothalamate meglumine with 81 mg/mL organically bound iodine. Manufactured by Liebel-Flarsheim Company LLC, Raleigh, NC, USA. Features storage and usage instructions, barcode, and lot details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.